Cancer cells spread by releasing 'bubbles', according to an MUHC study

April 22, 2008

A new fundamental mechanism of how tumour cells communicate has just been discovered by the team of Dr. Janusz Rak at the Research Institute of the McGill University Health Centre (MUHC) in collaboration with Dr Guha from the University of Toronto. The cancer cells are able to communicate with their more healthy counter-parts by releasing vesicles. These bubble-like structures contain cancer-causing (oncogenic) proteins that can trigger specific mechanisms when they merge into non or less-malignant cells. These findings could change our view on how cancerous tissues work and lead to major clinical innovations. They were published on April 20 in the on-line edition of Nature Cell Biology.

The surface of some brain tumour cells has long been known to express a mutated version of what is called the variant III epidermal growth factor receptor (EGFRvIII). Although this factor is expressed only in a fraction of tumour cells, it has a major impact on the malignancy of the whole tumor. How could this cellular minority have such an important impact" This mechanism was still unknown- until now.

This study shows that the mutated EGFRvIII triggers production of small vesicles that project from the cell membrane and that carry mutated copies of EGFRvIII on their surfaces. They were baptised "oncosomes." Surprisingly enough, this shows that oncoproteins are not always confined to the cell that produced them. In this case they even migrate!

Oncosomes will migrate until they fuse with another cell, either healthy or benign tumoral. Oncogenic protein AGFRvIII then becomes integrated in the membrane of the "recipient" cell and starts stimulating specific metabolic pathways to make it act in an aberrant and malignant way. Although this may be a transient event, the changes could impact tumor behaviour by more rapid increases in cell numbers and by stimulation of blood vessel growth, hallmarks of malignant brain tumors.

"With this information we can imagine that many mutant proteins are not necessarily confined to the cells that make them, but rather can migrate and spread around as cargo of oncosomes, a process that could be referred to as formation of the "oncogenic field effect," explained Dr. Rak. "It demonstrates that cancer is a multi-cell process, where the cells talk to one another extensively. This goes against the traditional view that a single 'mutated' cell will simply multiply uncontrollably to the point of forming a tumour. This discovery opens exciting new research avenues, but we also hope that it will lead to positive outcomes for patients."

Indeed, the presence of oncosomes (containing EGFRvIII or other proteins) in blood of cancer patients could become a clinical marker, meaning that doctors could screen for a tumour's molecular characteristics instead of having to perform invasive surgery or biopsy. Currently, in the case of brain cancer, this very precise assessment cannot be performed without removing the tumour and therefore opening a patient's skull. However, the assay and analysis of oncosomes would potentially only require taking a small sample of blood or cerebrospinal fluid. This would be a step in ensuring patient comfort and choosing the best therapeutic strategy for them, factors that are key in the journey towards personalized medicine in a hopefully not-too-distant future.

McGill University Health Centre

---

---

	One Renegade Cell: How Cancer Begins (Science Masters Series) by Robert A. Weinberg (Author) One of the leading cancer researchers in the world, Robert A. Weinberg is perfectly suited to describe the search for cancer's origins from the early days of this century to the present. Presuming little knowledge of biology, he tells how a cancer-causing virus was first discovered in 1909, how the correlation was made between chemical carcinogens and cancer, and how oncogenes (the genes that can turn a cell malignant) work. He explains clearly how malignant cells send messages to one another and also block the messages of normal cells. Finally, Weinberg predicts that cancer prevention may depend on our ability to understand the mysterious chemical clock that regulates our cells' most basic functions. One Renegade Cell offers a concise, accessible route into the complex and often daunting...
	The Biology of Cancer by Robert A. Weinberg (Author) The Biology of Cancer is a textbook for undergraduate and graduate biology students as well as medical students studying the molecular and cellular bases of cancer. The book presents the principles of cancer biology in an organized, cogent, and in-depth manner. The clarity of writing and the lucid full-color art program make the book accessible and engaging. The information unfolds through the presentation of key experiments which give readers a sense of discovery and provides insights into the conceptual foundation underlying modern cancer biology. The Biology of Cancer synthesizes the findings of three decades of recent cancer research and proposes a conceptual framework from which to teach about these discoveries. It provides the necessary structure, organization, and content for a...
	Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics by Lauren Pecorino (Author) Many of the cells in our body undergo tightly regulated replication to enable growth to occur and to ensure that damaged or worn out tissues are replaced. Regulation is mediated via many different mechanisms. It is when these mechanisms fail, and regulation is lost, that cancer can result. Recent advances in molecular cell biology have greatly expanded our understanding of the processes and mechanisms which underpin the regulation of cell replication, and what is happening at the molecular level when these fail. Now in its second edition, The Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics gives a fresh approach to the study of the molecular basis of cancer. Written with the undergraduate student in mind, Lauren Pecorino focuses on how our understanding of the...
	Cancer Biology by Raymond W. Ruddon M.D. (Author) A thorough yet concise account of cancer biology, this book emphasises the cellular and molecular mechanisms involved in the transformation of normal into malignant cells, the invasiveness of cancer cells into host tissues, and the metastatic spread of cancer cells in the host organism. It also defines the fundamental pathophysiological changes that occur in tumour tissue and in the host animal or patient. The approach throughout the book is to discuss the historical development of a field, citing the key experimental advances to the present day, and to evaluate the current evidence that best supports or rules out concepts of the molecular and cellular mechanisms regulating cancer cell behaviour. For all the areas of fundamental cancer research, an effort has been made to relate basic...
	Medifocus Guidebook on: Small Cell Lung Cancer by Medifocus.com (Author), Elliot Jacob PhD. (Editor) The MediFocus Guidebook on Small Cell Lung Cancer is the most comprehensive, up-to-date source of information available. You will get answers to your questions, including risk factors of Small Cell Lung Cancer, standard and alternative treatment options, leading doctors, hospitals and medical centers that specialize in Small Cell Lung Cancer, results of the latest clinical trials, support groups and additional resources, and promising new treatments on the horizon. This one of a kind Guidebook offers answers to your critical health questions including the latest treatments, clinical trials, and expert research; high quality, professional level information you can trust and understand culled from the latest peer-reviewed journals; and a unique resource to find leading experts,...
	Cancer: The Outlaw Cell by Richard LaFond (Editor) We live in an era in which scientific information grows by the day and is so specialized that no one person can possibly absorb and kept abreast of the literature. Substantial developments in science and medicine, powered by developing technologies such as genetic sequencing, proteomics, and nanobiology, have driven cancer research forward, and a review of where we are now is desperately needed. Cancer: The Outlaw Cell is a collection of twenty-five focused chapters written by leading researchers at the forefront of cancer research. Authors present the current state of knowledge in chapters on the role of heredity, cancer and telomeres, tumor resistance, and microRNAs in the pathogenesis of cancer, and map out areas of future research and advancement.
	Cancer Stem Cells: Identification and Targets by Sharmila A. Bapat (Editor) Because the concept and discoveries of cancer stem cells are relatively new, scientists and researchers need an introduction to this dynamic area. Cancer Stem Cells presents a consolidated account of the research done to date and recent progresses in the studies of cancer stem cells. Such a presentation facilitates a better understanding of and draws attention to stem cell and cancer biology - two fields that enhance, move, and evolve into each other continuously. It provides an informative study in designing approaches to apply stem cell principles to cancer biology while offering an overview of the challenges in developing combination stem and cancer biology targets for therapeutics. This book serves as a primer for new researchers in the field of cancer biology.
	Cancer SACKED! The True Story of How Don Martin Defeated "Terminal" Cancer in 4 Months by Rediscovering a Lost Cure--and You Can Too! For those who seek sensational, exaggerated, or preposterous “cure-all” stories—this book IS NOT for you! If however, you seek simple truth and genuine hope for yourself or a loved one stricken with a long, almost certain, death sentence—then this TRUE STORY of how Don Martin cured his “terminal cancer” IS for you! Within these pages, you will learn how a wonderful cancer-cure was “mysteriously lost” from humanity--only to be "discovered" 4 more times! CANCER SACKED raises the question: “How can poisoning, burning, and slashing a person, restore them back to health?” Envision the family struggling to find hope for a suffering loved one. Is this why they call it “cancer treatment” rather than “cancer cure?” Which should be the goal?...
	The Skin Cancer Answer: The Natural Treatment for Basal and Sqamous Cell Carcinomasand Keratoses by William I. Lane (Author), Linda Comac (Author) In spite of the steady stream of news about medical breakthroughs, some diseases are on the rise. Nonmelanoma skin cancers (squamous and basal cell carcinomas) occur as often as all other cancers combined. With their previous book on the use of shark cartilage as an anticarcinogen, I. William Lane and Linda Comac challenged the medical establishment. In The Skin Cancer Answer, they now offer a revolutionary approach to skin cancer treatment, describing in a reader-friendly tone the history, use, and effectiveness of a thoroughly tested vegetable component, which is easily applied.
	Cancer: The Evolutionary Legacy by Mel Greaves (Author) Every day, 1500 Americans die of cancer, and yet for most of us this deadly disease remains mysterious. Why is it so common? Why are there so many different causes? Why does treatment so often fail? What, ultimately, is cancer? In this fascinating new book, a leading cancer researcher offers general readers clear and convincing answers to these and many other questions. Mel Greaves places cancer in its evolutionary context, arguing that we can best answer the big questions about cancer by looking through a Darwinian lens. Drawing on both ancient and more modern evolutionary legacies, he shows how human development has changed the rules of evolutionary games, trapping us in a nature-nurture mismatch. Compelling examples, from the King of Naples intestinal tumor in the 15th...